Publication date: Jun 24, 2025

Moreover, because mitochondrial rewiring fuels resistance across many cancers, success in melanoma could open the door to similar personalized combination strategies in other hard-to-treat cancers. Researchers have discovered that the most aggressive melanomas, the deadliest form of skin cancer, overactivate two key processes in mitochondria, the components of cells that provide energy. By pairing mitochondrial blockers with today’s standards of care, we may cut off a major escape route that cancers use to resist therapy and come back. ” Two types of drugs accomplished this: antibiotics-originally designed to block bacterial protein synthesis machinery, which closely resembles the machinery found in mitochondria-and specialized energy-production inhibitors. Blocking these pathways with currently available drugs effectively killed melanoma cells. By enabling clinicians to match treatments to each patient’s tumor biology, these findings mark a step forward for precision medicine in melanoma. Jeovanis Gil, PhD, senior author of Lund University, SwedenDr.

Semantics

Original Article